Cargando…

Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis

BACKGROUND: Surveillance for hepatocellular carcinoma (HCC) has level I evidence among patients with hepatitis B but only level II evidence in patients with cirrhosis. This lack of randomized data has spurred questions regarding the utility of HCC surveillance in this patient population; however, la...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singal, Amit G., Pillai, Anjana, Tiro, Jasmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972088/ https://www.ncbi.nlm.nih.gov/pubmed/24691105 http://dx.doi.org/10.1371/journal.pmed.1001624

Ejemplares similares

Racial, Ethnic, and Socioeconomic Disparities in Curative Treatment Receipt and Survival in Hepatocellular Carcinoma
por: Wagle, Nikita Sandeep, et al.
Publicado: (2021)

Gaps in hepatocellular carcinoma surveillance among insured patients with hepatitis B infection without cirrhosis in the United States
por: Nguyen, Mindie H., et al.
Publicado: (2022)

Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis
por: Elshaarawy, Omar, et al.
Publicado: (2021)

Is hepatocellular carcinoma surveillance in high-risk populations effective?
por: Onyirioha, Kristeen, et al.
Publicado: (2020)

Effects of Curative-Intent Treatments on Hepatocellular Carcinoma Survival in Alcohol-Related Cirrhosis: A Nationwide Study
por: Kraglund, Frederik, et al.
Publicado: (2023)

Comment on “Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis”
por: Tang, Xiao-Long, et al.
Publicado: (2022)

Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma
por: Lee, Yi-Te, et al.
Publicado: (2023)

Hepatocellular Carcinoma Screening Process Failures in Patients with Cirrhosis
por: Marquardt, Patrick, et al.
Publicado: (2021)

Role of imaging in management of hepatocellular carcinoma: surveillance, diagnosis, and treatment response
por: Osho, Azeez, et al.
Publicado: (2020)

Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
por: Seif El Dahan, Karim, et al.
Publicado: (2023)

Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?
por: Hanouneh, Ibrahim A., et al.
Publicado: (2019)

The Actual Five-year Survival Rate of Hepatocellular Carcinoma Patients after Curative Resection
por: Lee, Jae Gil, et al.
Publicado: (2006)

Survival rates of early-stage HCV-related liver cirrhosis patients without hepatocellular carcinoma are decreased by alcohol
por: Yamada, Masayoshi, et al.
Publicado: (2011)

Histological Severity of Cirrhosis Influences Surgical Outcomes of Hepatocellular Carcinoma After Curative Hepatectomy
por: Liang, Bin-Yong, et al.
Publicado: (2022)

Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 Pandemic
por: Mehta, Neil, et al.
Publicado: (2021)

A Biomarker Panel Based upon AFP, Fucosylated Kininogen and PEG-Precipitated IgG Is Highly Accurate for the Early Detection Hepatocellular Carcinoma in Patients with Cirrhosis in Phase II and Phase III Biomarker Evaluation
por: Wang, Mengjun, et al.
Publicado: (2022)

Surveillance programmes for early detection of hepatocellular carcinoma
por: Simon, Krzysztof, et al.
Publicado: (2012)

Cost-Effectiveness of Risk Score–Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis
por: Goossens, Nicolas, et al.
Publicado: (2017)

Surveillance of cirrhosis for hepatocellular carcinoma: a cost–utility analysis
por: Thompson Coon, J, et al.
Publicado: (2008)

Surveillance for Hepatocellular Carcinoma after Autologous Stem Cell Transplantation in Cirrhosis
por: Mohamadnejad, Mehdi, et al.
Publicado: (2012)

Acute kidney injury after multiphase imaging for lesions detected on hepatocellular carcinoma surveillance in patients with cirrhosis
por: Khan, Adnan Aman, et al.
Publicado: (2020)

Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort
por: Parikh, Neehar D., et al.
Publicado: (2022)

Rate of hepatocellular carcinoma surveillance remains low for a large, real-life cohort of patients with hepatitis C cirrhosis
por: Tran, Sally Ann, et al.
Publicado: (2018)

Cholecystectomy is associated with higher risk of early recurrence and poorer survival after curative resection for early stage hepatocellular carcinoma
por: Li, Tao, et al.
Publicado: (2016)

Effectiveness and safety of atezolizumab-bevacizumab in patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysis
por: Kulkarni, Anand V., et al.
Publicado: (2023)

Impact of cirrhosis aetiology on incidence and prognosis of hepatocellular carcinoma diagnosed during surveillance
por: Ganne-Carrié, Nathalie, et al.
Publicado: (2021)

Comparison of a multitarget blood test to ultrasound and alpha‐fetoprotein for hepatocellular carcinoma surveillance: Results of a network meta‐analysis
por: Singal, Amit G., et al.
Publicado: (2022)

Assessment of a Deep Learning Model to Predict Hepatocellular Carcinoma in Patients With Hepatitis C Cirrhosis
por: Ioannou, George N., et al.
Publicado: (2020)

Curative Effects of Fuzheng Huayu on Liver Fibrosis and Cirrhosis: A Meta-Analysis
por: Dong, Shu, et al.
Publicado: (2015)

Comparable Overall Survival in Patients with Hepatocellular Carcinoma Diagnosed within and outside a Surveillance Programme: The Potential Impact of Liver Cirrhosis
por: Faulkes, Rosemary E., et al.
Publicado: (2023)

Rates of cirrhosis and hepatocellular carcinoma in chronic hepatitis B and the role of surveillance: a 10-year follow-up of 673 patients
por: Poh, Zhongxian, et al.
Publicado: (2015)

Assessment of the Surveillance Interval at 1 Year after Curative Treatment in Hepatocellular Carcinoma: Risk Stratification
por: Lee, Minjong, et al.
Publicado: (2018)

Serologic status and safety of inactivated Covid‐19 vaccine for hepatocellular carcinoma patients with cirrhosis after curative liver resection
por: Liu, Fuchen, et al.
Publicado: (2022)

Model to Predict Overall Survival in Patients With Hepatocellular Carcinoma After Curative Hepatectomy
por: Zhang, Li-xiang, et al.
Publicado: (2021)

Risk of Liver Cirrhosis and Hepatocellular Carcinoma after Fontan Operation: A Need for Surveillance
por: Yoon, Jun Sik, et al.
Publicado: (2020)

Factors influencing early recurrence of hepatocellular carcinoma after curative resection
por: Zhu, Yu, et al.
Publicado: (2020)

Relationship between serum alpha-foetoprotein, cirrhosis and survival in hepatocellular carcinoma.
por: Johnson, P. J., et al.
Publicado: (1981)

Prognostic Analysis of Postoperative Survival for Ruptured Hepatocellular Carcinoma with or without Cirrhosis
por: Xia, Feng, et al.
Publicado: (2022)

A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis
por: Biselli, M, et al.
Publicado: (2015)

Individual surveillance by competing risk model for patients with hepatocellular carcinoma occurrence in all-cause cirrhosis
por: Wang, Qi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0393q86qarln5t862vtngtudq4